View on Pubmed.gov 21474794 | View on doi.org 10.1074/mcp.M11...
Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae.
- Medical School, University of Sheffield, Sheffield, UK.
Abstract
Macrophages are central effectors of innate immune responses to bacteria. We have investigated how activation of the abundant macrophage lysosomal protease, cathepsin D, regulates the macrophage proteome during killing of Streptococcus pneumoniae. Using the cathepsin D inhibitor pepstatin A, we demonstrate that cathepsin D differentially regulates multiple targets out of 679 proteins identified and quantified by eight-plex isobaric tag for relative and absolute quantitation. Our statistical analysis identified 18 differentially expressed proteins that passed all paired t-tests (α = 0.05). This dataset was enriched for proteins regulating the mitochondrial pathway of apoptosis or inhibiting competing death programs. Five proteins were selected for further analysis. Western blotting, followed by pharmacological inhibition or genetic manipulation of cathepsin D, verified cathepsin D-dependent regulation of these proteins, after exposure to S. pneumoniae. Superoxide dismutase-2 up-regulation was temporally related to increased reactive oxygen species generation. Gelsolin, a known regulator of mitochondrial outer membrane permeabilization, was down-regulated in association with cytochrome c release from mitochondria. Eukaryotic elongation factor (eEF2), a regulator of protein translation, was also down-regulated by cathepsin D. Using absence of the negative regulator of eEF2, eEF2 kinase, we confirm that eEF2 function is required to maintain expression of the anti-apoptotic protein Mcl-1, delaying macrophage apoptosis and confirm using a murine model that maintaining eEF2 function is associated with impaired macrophage apoptosis-associated killing of Streptococcus pneumoniae. These findings demonstrate that cathepsin D regulates multiple proteins controlling the mitochondrial pathway of macrophage apoptosis or competing death processes, facilitating intracellular bacterial killing.
References
Proteomics. 2010 Sep;10(17):3130-41
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):4952-7
PLoS Pathog. 2007 Mar;3(3):e51
J Immunol. 2008 Jul 1;181(1):698-711
Cited by 42 citations (total)
Journal Article Research Support, Non-U.S. Gov't
Alkaptonuria is a novel human secondary amyloidogenic disease.
Electronic publication date November 14, 2012
Lia Millucci [...] Annalisa Santucci et al.
Alkaptonuria (AKU) is an ultra-rare disease developed from the lack of homogentisic acid oxidase activity, causing homogentisic acid (HGA) accumulation...
Journal Article Research Support, Non-U.S. Gov't
Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans.
Electronic publication date February 2, 2021
Lingling Ding [...] Ronit Shiri-Sverdlov et al.
AIMS/HYPOTHESIS
Insulin resistance in skeletal muscle and liver plays a major role in the pathophysiology of type 2 diabetes. The hyperinsulinaemic-euglycaemic...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •